Startseite>>Signaling Pathways>> Antibody-drug Conjugate/ADC Related>> Drug-Linker Conjugates for ADC>>DBM-MMAF

DBM-MMAF

Katalog-Nr.GC65359

DBM-MMAF ist ein Wirkstoff-Linker-Konjugat, das aus einem wirksamen Antitubulin-Wirkstoff MMAF und einem Linker-DBM besteht, um ein AntikÖrper-Wirkstoff-Konjugat (ADC) herzustellen.

Products are for research use only. Not for human use. We do not sell to patients.

DBM-MMAF Chemische Struktur

Cas No.: 1810001-93-4

Größe Preis Lagerbestand Menge
5mg
405,00 $
Auf Lager
10mg
720,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents

DBM-MMAF is a drug-linker conjugate composed of a potent antitubulin agent MMAF and a linker DBM to make antibody drug conjugate (ADC)[1].

[1]. Lee JW, et al. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 1;16(9):2562-70.

Bewertungen

Review for DBM-MMAF

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DBM-MMAF

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.